131 related articles for article (PubMed ID: 38598452)
1. Ablative Radioembolization (SIRT) of a Large Inoperable Renal Cell Carcinoma Invading the Liver That Resulted in Hematuria Control and Complete Necrosis by mRECIST Criteria.
Spyridonidis I; Dimopoulos P; Spyridonidis T; Christopoulou A; Katsanos K
Clin Nucl Med; 2024 Jun; 49(6):557-558. PubMed ID: 38598452
[TBL] [Abstract][Full Text] [Related]
2. Transarterial Yttrium-90 Radioembolization Treatment of Patients with Liver-Dominant Metastatic Renal Cell Carcinoma.
Kis B; Shah J; Choi J; El-Haddad G; Sweeney J; Biebel B; Mellon E; Frakes JM; Hoffe SE; Fishman MN; Shridhar R
J Vasc Interv Radiol; 2017 Feb; 28(2):254-259. PubMed ID: 27955832
[TBL] [Abstract][Full Text] [Related]
3. Yttrium-90 radioembolization of renal cell carcinoma metastatic to the liver.
Abdelmaksoud MH; Louie JD; Hwang GL; Kothary N; Minor DR; Sze DY
J Vasc Interv Radiol; 2012 Mar; 23(3):323-30.e1. PubMed ID: 22277275
[TBL] [Abstract][Full Text] [Related]
4. Ablative Radioembolization of a Synchronous Renal Cell Carcinoma and Hepatocellular Carcinoma.
McGregor H; Laidlaw G; Johnson G
J Vasc Interv Radiol; 2023 Oct; 34(10):1847-1849. PubMed ID: 37391075
[No Abstract] [Full Text] [Related]
5. CT of the kidneys: what size are renal cell carcinomas when they cause symptoms or signs?
Dahlman P; Brekkan E; Magnusson A
Scand J Urol Nephrol; 2007; 41(6):490-5. PubMed ID: 17853020
[TBL] [Abstract][Full Text] [Related]
6. Role of Radioembolization in the Management of Liver-Dominant Metastatic Renal Cell Carcinoma: A Single-Center, Retrospective Study.
Bibok A; Mhaskar R; Jain R; Zhang J; Frakes J; Hoffe S; El-Haddad G; Parikh N; Ahmed A; Fishman MN; Choi J; Kis B
Cardiovasc Intervent Radiol; 2021 Nov; 44(11):1755-1762. PubMed ID: 34312688
[TBL] [Abstract][Full Text] [Related]
7. Sarcomatoid renal cell carcinoma: a case report and literature review.
Liang X; Liu Y; Ran P; Tang M; Xu C; Zhu Y
BMC Nephrol; 2018 Apr; 19(1):84. PubMed ID: 29636020
[TBL] [Abstract][Full Text] [Related]
8. A child with sickle cell trait and macroscopic hematuria. Renal cell carcinoma.
Tawadrous HK; Liu W; Amodio J; Nicastri A; Schoeneman MJ
Pediatr Nephrol; 2009 Jul; 24(7):1307, 1309-12. PubMed ID: 18989709
[No Abstract] [Full Text] [Related]
9. Renal cell carcinoma presenting as an upper gastrointestinal bleeding.
Mohamed MO; Al-Rubaye S; Reilly IW; McGoldrick S
BMJ Case Rep; 2015 Aug; 2015():. PubMed ID: 26276850
[TBL] [Abstract][Full Text] [Related]
10. A rare case of peliosis hepatis in a patient with chronic renal failure and renal cell carcinoma.
Maruyama H; Takahashi K; Ishikawa N; Hosaka K; Kumaki D; Aruga Y; Yamakawa M; Hirano M; Funakoshi K; Terai S
Clin J Gastroenterol; 2020 Jun; 13(3):403-407. PubMed ID: 31713159
[TBL] [Abstract][Full Text] [Related]
11. RESIRT: A Phase 1 Study of Selective Internal Radiation Therapy Using Yttrium-90 Resin Microspheres in Patients With Primary Renal Cell Carcinoma.
de Souza PL; Aslan P; Clark W; Nour R; de Silva S
Clin Genitourin Cancer; 2022 Oct; 20(5):442-451. PubMed ID: 35710899
[TBL] [Abstract][Full Text] [Related]
12. Radiological case of the month. Renal cell carcinoma in a child with hemoglobin SA disease.
Kawanami T; Young LW; Wood BP
Am J Dis Child; 1988 Jul; 142(7):783-4. PubMed ID: 3381785
[No Abstract] [Full Text] [Related]
13. Percutaneous Cryoablation of the Horseshoe Kidney: An Initial Experience.
Huang J; Atwell TD; Kurup AN; Boorjian SA; Thompson RH; Schmit GD
J Vasc Interv Radiol; 2017 Apr; 28(4):498-501. PubMed ID: 28343584
[TBL] [Abstract][Full Text] [Related]
14. Gross Hematuria Eight Years Following Nephrectomy for Renal Cell Cancer.
Steadman SD; Canales BK
Urology; 2020 Sep; 143():1-4. PubMed ID: 32505621
[No Abstract] [Full Text] [Related]
15. 18F-FDG PET/CT predicts survival after radioembolization of hepatic metastases from breast cancer.
Haug AR; Tiega Donfack BP; Trumm C; Zech CJ; Michl M; Laubender RP; Uebleis C; Bartenstein P; Heinemann V; Hacker M
J Nucl Med; 2012 Mar; 53(3):371-7. PubMed ID: 22331219
[TBL] [Abstract][Full Text] [Related]
16. Can pretreatment hepatic artery perfusion scintigraphy in patients with liver malignancies predict the treatment response of the selective internal radiation therapy with 90Y resin microspheres?
Guney IB; Balli HT; Kucuker KA; Unal I; Kibar M
Diagn Interv Radiol; 2022 Mar; 28(2):156-165. PubMed ID: 35548900
[TBL] [Abstract][Full Text] [Related]
17. [A case of renal cell carcinoma difficult to diagnose preoperatively because of hypovascular findings].
Nakajima H; Yui Y; Tsuboi N; Yoshida K; Akimoto M
Hinyokika Kiyo; 1985 Jun; 31(6):1021-5. PubMed ID: 3864364
[TBL] [Abstract][Full Text] [Related]
18. Angiosomal radiopathologic analysis of transarterial radioembolization for the treatment of hepatocellular carcinoma.
Ahmed AF; Samreen N; Grajo JR; Zendejas I; Sistrom CL; Collinsworth A; Esnakula A; Shah JL; Cabrera R; Geller BS; Toskich BB
Abdom Radiol (NY); 2018 Jul; 43(7):1825-1836. PubMed ID: 29052747
[TBL] [Abstract][Full Text] [Related]
19. [A case of bilateral renal cell carcinoma].
Hara M; Nakagami Y; Hiraoka Y; Lin T
Hinyokika Kiyo; 1985 Oct; 31(10):1787-91. PubMed ID: 4091127
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial.
Vilgrain V; Pereira H; Assenat E; Guiu B; Ilonca AD; Pageaux GP; Sibert A; Bouattour M; Lebtahi R; Allaham W; Barraud H; Laurent V; Mathias E; Bronowicki JP; Tasu JP; Perdrisot R; Silvain C; Gerolami R; Mundler O; Seitz JF; Vidal V; Aubé C; Oberti F; Couturier O; Brenot-Rossi I; Raoul JL; Sarran A; Costentin C; Itti E; Luciani A; Adam R; Lewin M; Samuel D; Ronot M; Dinut A; Castera L; Chatellier G;
Lancet Oncol; 2017 Dec; 18(12):1624-1636. PubMed ID: 29107679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
